Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000386798 | SCV000345445 | benign | not specified | 2016-08-26 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000386798 | SCV000711264 | benign | not specified | 2016-06-20 | criteria provided, single submitter | clinical testing | p.Ala307Ala in exon 10 of OTOA: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.7% (63/8630) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs12051473). |
Athena Diagnostics | RCV000386798 | SCV001476586 | benign | not specified | 2019-10-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001668625 | SCV001885746 | benign | not provided | 2018-10-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001668625 | SCV002410125 | benign | not provided | 2024-09-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920168 | SCV004737326 | likely benign | OTOA-related disorder | 2019-03-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |